SB3046 — PHARMACEUTICALS-SOCIAL MEDIA
Last action — Rule 3-9(a) / Re-referred to Assignments
-
1Introduced
-
2In Committee
-
3Passed Senate
-
4Passed House
-
5To Executive
-
6Enacted
This bill has been introduced in the Senate. Introduced January 29, 2026. It must pass committee before a floor vote.
Next likely step: a committee referral and hearing.
Odds of enactment
Low chanceBased on the sponsor, cosponsors, and committee posture, this bill has a low chance of becoming law.
Upgrade to see the exact probability and what's driving it.
A statistical estimate from our own model of past outcomes — an insight, not a guarantee. Policymaking is volatile.
Prognosis
Not enough signal yet to read this bill's trajectory — we surface a likelihood only once there's real movement (stage, sponsorship, committee, or votes) to point to.
Based on stage, sponsorship breadth, committee status, recorded votes, and cross-state momentum — a description of the observable signals, not a prediction.
In plain language
This bill regulates the sale of pharmaceuticals on social media platforms.
The bill establishes that individuals must complete a verification process before selling or advertising pharmaceuticals on social media. It defines specific terms related to the sale of pharmaceuticals.
Summary
Creates the Sale of Pharmaceuticals on Social Media Act. Provides that, notwithstanding any other provision of law, no individual shall sell or advertise the sale of a pharmaceutical on social media unless the individual has completed a verification process with specified requirements. Defines terms.
Bill Text
We don't have the full text on file for this bill yet.
Read SB3046 on the official Illinois source →Action History
-
Rule 3-9(a) / Re-referred to Assignments
-
Rule 2-10 Committee/3rd Reading Deadline Established As May 22, 2026
-
Rule 2-10 Committee/3rd Reading Deadline Established As May 15, 2026
-
Rule 2-10 Committee Deadline Established As April 24, 2026
-
Rule 2-10 Committee Deadline Established As March 27, 2026
-
To AI and Social Media
-
Assigned to Executive
-
Referred to Assignments
-
First Reading
-
Filed with Secretary by Sen. Sue Rezin
Sponsors
- Sue Rezin · Primary
Sponsorship breakdown
Export CSV (upgrade) →1 sponsors · 0 co-sponsors · 182 not signed on
Sponsors (1)
- Sue Rezin Republican
Co-sponsors (0)
None.
Not signed on (182)
182 members have not signed on to this bill.
Show all 182 →"Not signed on" means a member has not sponsored or co-sponsored this bill — it does not imply opposition. Members flagged Voted No have a recorded No vote on this bill.
Subjects
Frequently asked questions
- What does SB3046 do?
- Creates the Sale of Pharmaceuticals on Social Media Act. Provides that, notwithstanding any other provision of law, no individual shall sell or advertise the sale of a pharmaceutical on social media unless the individual has completed a verification process with specified requirements. Defines terms.
- Who sponsors SB3046 ?
- SB3046 is sponsored by Sue Rezin (Republican).
- What is the current status of SB3046 ?
- This bill has been introduced in the Senate. Introduced January 29, 2026. It must pass committee before a floor vote.
- Where can I track SB3046 ?
- Track SB3046 free on One Click Politics — get push/email alerts when it moves.
Make your voice heard on SB3046
Find the representatives who decide this bill and tell them where you stand — for yourself, or mobilize your whole list in one click with One Click Politics advocacy software.
Stay ahead of SB3046
Last checked for changes 3 months ago · updated continuously
One Click Politics tracks every bill in Congress and all 50 states.
Track this bill →